Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804023 · ClinicalTrials.gov registry record
Biomarkers of Protocol Compliance and Product Adherence
A clinical trial of HIV Prevention, sponsored by CONRAD.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT01804023: Completed study of HIV Prevention, sponsored by CONRAD.
NCT01804023 is a study of HIV Prevention that has completed, run by CONRAD. The registered enrollment target is 40 participants, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01804023, a study of HIV Prevention, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare tests of vaginal insertion of applicators(visual inspection of returned applicators (VIRA), inspection of returned applicators under ultraviolet (UV) light, and DNA/protein markers) to determine which, if any, warrant use in a clinical trial of a new vaginal microbicide. The study will also determine whether indicators of semen can be detected on applicators and the degree to which they correlate with reported intercourse, and the correlation between vaginal bacteria detected by a vaginal swab and those detected from the applicator. In addition, the study will determine whether several factors that may be encountered in a clinical trial are likely to affect detection of these markers, including storage for 30 days vs. 7 days, wiping applicators after use, the presence of gel, and inter- and intra-woman variability. The study will also assess safety.
Conditions Studied
Interventions
- OTHER HEC placebo gel applicators
Study Locations (1)
Virginia
- Clinical Research Center, Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-09 |
What the finished NCT01804023 record still lists
NCT01804023 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (90% lower).
The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which HEC placebo gel applicators is the first listed.
NCT01804023 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT01804023 about?
NCT01804023 is a clinical study titled "Biomarkers of Protocol Compliance and Product Adherence". The purpose of this study is to compare tests of vaginal insertion of applicators(visual inspection of returned applicators (VIRA), inspection of returned applicators under ultraviolet (UV) light, and DNA/protein markers) to determine which, if any, warrant use in a clinical trial of a new vaginal m...
What is the current status of trial NCT01804023?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-03. Estimated completion is 2013-09.
What conditions does trial NCT01804023 study?
This clinical trial studies the following conditions: HIV Prevention.
What interventions are being tested in trial NCT01804023?
The interventions under investigation include: HEC placebo gel applicators (OTHER).
Who is sponsoring clinical trial NCT01804023?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01804023 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01804023's enrollment target sits among peer trials
40 27th of 32 higher than 5 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
RECRUITING · Phase 1
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia